AMP Launches HANAFSAN Branded CBD Cannabis Cosmetics Products in Germany
News provided by
Share this article
Share this article
ERFURT, Germany and BERLIN and VORARLBERG, Austria, May 12, 2021 /CNW/ - AMP Alternative Medical Products Inc. (Frankfurt: C4TA) (ISIN: CA0318961038) (CSE: XCX), a pharmaceutical supplier of medical cannabis products to German pharmacies and Dr. Feurstein Medical Hemp GmbH ( HANAFSAN ), an Austrian pharmaceutical CBD hemp producer have entered into a supply agreement to import and sell HANAFSAN branded certified CBD Hemp cosmetics in Germany.
HANAFSAN (CNW Group/AMP Alternative Medical Products Inc.)
AMP will import a range of pharmaceutical grade CBD cosmetics under the HANAFSAN brand name for sale in Germany. These cosmetics are produced from hemp organically cultivated in Europe and processed and manufactured at their EU-GMP compliant facility in Vorarlberg, Austria. HANAFSAN CBD cosmetic products are already certified for sale in Germany witho
AMP Appoints National Sales Director and Launches Nationwide Marketing Sales Campaign for Branded Medical Cannabis Products in Germany yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
Aphria Inc. Logo (CNW Group/AMP German Cannabis Group Inc.)
ERFURT/BERLIN/DENSBORN, Germany, and LEAMINGTON, ON, Canada, Jan. 26, 2021 /CNW/ - AMP German Cannabis Group Inc. (
AMP ) (CSE: XCX), (Frankfurt: C4T) (ISIN: CA00176G1028) and Aphria Inc. s (
Aphria ) (TSX: APHA) (NASDAQ: APHA) wholly-owned German subsidiary, CC Pharma GmbH (
CC Pharma ), have entered into a strategic agreement (the
Co-Promotion Agreement ) covering joint marketing of sales for Aphria brand medical cannabis products for the German market.
The Co-Promotion Agreement is a collaboration contract between AMP and CC Pharma to sell the Aphria medical cannabis brand in Germany. In addition, AMP will organize with the support of CC Pharma, information events in Germany to market Aphria branded products to doctors and pharmacists.
Aphria Inc. Logo (CNW Group/AMP German Cannabis Group Inc.)
ERFURT/BERLIN/DENSBORN, Germany, and LEAMINGTON, ON, Canada, Jan. 26, 2021 /CNW/ - AMP German Cannabis Group Inc. (
AMP ) (CSE: XCX), (Frankfurt: C4T) (ISIN: CA00176G1028) and Aphria Inc. s (
Aphria ) (TSX: APHA) (NASDAQ: APHA) wholly-owned German subsidiary, CC Pharma GmbH (
CC Pharma ), have entered into a strategic agreement (the
Co-Promotion Agreement ) covering joint marketing of sales for Aphria brand medical cannabis products for the German market.
The Co-Promotion Agreement is a collaboration contract between AMP and CC Pharma to sell the Aphria medical cannabis brand in Germany. In addition, AMP will organize with the support of CC Pharma, information events in Germany to market Aphria branded products to doctors and pharmacists.